Transfection of Sb9 in hepatocytes confers resistance to killing by cytotoxic T cells and hepatotoxicity, suggesting that delivery of Sb9 protein or transgene to liver might be a new strategy for prevention or treatment of GzmB-induced hepatitis (54, 107). The gene discussed is GZMB; the disease is hepatitis A virus infection.